Baker McKenzie represented Merit Medical Systems, Inc. (NASDAQ: MMSI), a global healthcare technology company, on its acquisition of View Point Medical, Inc., a privately held medical device company based in Carlsbad, California. The aggregate consideration was approximately USD 140 million, including USD 90 million in cash at closing and two deferred payments of USD 25 million each payable on the first and second anniversaries of closing.
The deal expands Merit’s therapeutic oncology portfolio with View Point’s OneMark® Detection Imaging System and OneMark® Tissue Markers, FDA cleared technologies that enhance lesion localization at the time of biopsy and complement Merit’s existing SCOUT® platform.
Led by M&A Partner Lewis Popoff, the team included:
- Corporate / M&A: Jeanne Song, Rachel Gray and Noah Walusis (Chicago)
- Commercial: Michelle Carr (Chicago)
- Intellectual Property: Jessica Greenwald (Dallas)
- FDA Regulation: Xin Tao and Lois Sheng Liu (Washington, DC)
- Tax: Ross Staine (Houston)
- Benefits & Executive Compensation: Chris Guldberg (Chicago)
- Employment: Kimberly Franko Lower (New York) and Loïc Coutelier (Palo Alto)
Learn more about the transaction: Merit Medical Acquires View Point Medical, Inc.
With more than 2,700 deal practitioners across 40+ jurisdictions, Baker McKenzie has the broadest footprint of any law firm and is recognized for seamlessly executing complex, cross border transactions. The Firm’s Healthcare & Life Sciences group is among the largest globally, drawing on six decades of sector knowledge to provide comprehensive legal services in transactions, regulatory investigations, and disputes across its global network.